Literature DB >> 25482313

Cellular and morphological aspects of fibrodysplasia ossificans progressiva. Lessons of formation, repair, and bone bioengineering.

Anderson Martelli1, Arnaldo Rodrigues Santos.   

Abstract

Fibrodysplasia ossificans progressiva (FOP) is a rare congenital disease that causes bone formation within the muscles, tendons, ligaments and connective tissues. There is no cure for this disorder and only treatment of the symptoms is available. The purpose of this study was to review the literature and describe the clinical, cellular and molecular aspects of FOP. The material used for the study was obtained by reviewing scientific articles published in various literature-indexed databases. In view of its rarity and of the lack of insightful information and the unpredictability of its course, FOP is a challenging disorder for professionals who are confronted by it. However, this rare disease raises a great deal of interest because understanding the mechanism of mature bone formation can encourage research lines related to bone regeneration and the prevention of heterotopic ossification.

Entities:  

Keywords:  cell differentiation; fibrodysplasia; heterotopic ossification; histomorphology; osteogenesis

Mesh:

Substances:

Year:  2014        PMID: 25482313      PMCID: PMC4750545          DOI: 10.4161/org.29206

Source DB:  PubMed          Journal:  Organogenesis        ISSN: 1547-6278            Impact factor:   2.500


  57 in total

1.  Restoration of normal BMP signaling levels and osteogenic differentiation in FOP mesenchymal progenitor cells by mutant allele-specific targeting.

Authors:  J Kaplan; F S Kaplan; E M Shore
Journal:  Gene Ther       Date:  2011-10-20       Impact factor: 5.250

Review 2.  Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts.

Authors:  F Shapiro
Journal:  Eur Cell Mater       Date:  2008-04-01       Impact factor: 3.942

3.  Fibrodysplasia ossificans progressiva.

Authors:  E R Tonholo-Silva; E A Adachi; M S Tafner; L Yoshinaga
Journal:  Arq Neuropsiquiatr       Date:  1994-03       Impact factor: 1.420

4.  Fibrodysplasia ossificans progressiva: case report.

Authors:  Andre Leite Gonçalves; Marcelo Rodrigues Masruha; Carmelinda Correia de Campos; Patricia Longo Ribeiro Delai; Luiz Celso Pereira Vilanova
Journal:  Arq Neuropsiquiatr       Date:  2005-12-15       Impact factor: 1.420

5.  Induction of new-bone formation in the host bed by human bone-tumor transplants in athymic nude mice.

Authors:  M R Urist; T T Grant; T S Lindholm; J M Mirra; H Hirano; G A Finerman
Journal:  J Bone Joint Surg Am       Date:  1979-12       Impact factor: 5.284

6.  ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development.

Authors:  Donghui Zhang; Edward M Schwarz; Randy N Rosier; Michael J Zuscik; J Edward Puzas; Regis J O'Keefe
Journal:  J Bone Miner Res       Date:  2003-09       Impact factor: 6.741

7.  Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration.

Authors:  J O Hollinger; J M Schmitt; D C Buck; R Shannon; S P Joh; H D Zegzula; J Wozney
Journal:  J Biomed Mater Res       Date:  1998

Review 8.  Transforming growth factor-beta isoforms and the induction of bone formation: implications for reconstructive craniofacial surgery.

Authors:  Ugo Ripamonti; Carlo Ferretti; June Teare; Leandra Blann
Journal:  J Craniofac Surg       Date:  2009-09       Impact factor: 1.046

9.  The face signature of fibrodysplasia ossificans progressiva.

Authors:  Peter Hammond; Michael Suttie; Raoul C Hennekam; Judith Allanson; Eileen M Shore; Frederick S Kaplan
Journal:  Am J Med Genet A       Date:  2012-05-11       Impact factor: 2.802

Review 10.  TGF-β and BMP signaling in osteoblast differentiation and bone formation.

Authors:  Guiqian Chen; Chuxia Deng; Yi-Ping Li
Journal:  Int J Biol Sci       Date:  2012-01-21       Impact factor: 6.580

View more
  7 in total

1.  Fibrodysplasia ossificans progressiva (FOP) presenting as a rapidly growing non-calcified neck mass.

Authors:  Ghiam Yamin; Shadi Daghighi; Mahmood Mafee
Journal:  J Radiol Case Rep       Date:  2021-05-31

2.  Fibrodysplasia ossificans progressiva: Diagnosis with ultrasound.

Authors:  Lino Piotto; Ajay Taranath
Journal:  Australas J Ultrasound Med       Date:  2021-05-05

3.  Gene activated adipose tissue fragments as advanced autologous biomaterials for bone regeneration: osteogenic differentiation within the tissue and implications for clinical translation.

Authors:  Bin Ren; Volker M Betz; Christian Thirion; Michael Salomon; Roland M Klar; Volkmar Jansson; Peter E Müller; Oliver B Betz
Journal:  Sci Rep       Date:  2019-01-18       Impact factor: 4.379

4.  Non-traumatic myositis ossificans circumscripta in the anterior abdominal wall of a seven-year-old Ugandan child: A case report.

Authors:  Hamdi Mohamed Isse; Senai Goitom Sereke; Mboizi Vincent; Muyinda Zeridah
Journal:  Clin Case Rep       Date:  2022-07-25

5.  Puerarin improves graft bone defect through microRNA‑155‑3p‑mediated p53/TNF‑α/STAT1 signaling pathway.

Authors:  Yang Zhou; Hongyu Lian; Kexin Liu; Deli Wang; Xuelian Xiu; Zhang Sun
Journal:  Int J Mol Med       Date:  2020-05-06       Impact factor: 4.101

Review 6.  Fibrodysplasia ossificans progressiva: current concepts from bench to bedside.

Authors:  Arun-Kumar Kaliya-Perumal; Tom J Carney; Philip W Ingham
Journal:  Dis Model Mech       Date:  2020-09-21       Impact factor: 5.758

7.  Cancellous bone-like tissue replacement from calcinosis in patients with systemic sclerosis with multiple external root resorption.

Authors:  Takumi Memida; Shinji Matsuda; Takashi Nakamoto; Kazuhisa Ouhara; Mikihito Kajiya; Shintaro Hirata; Eiji Sugiyama; Naoya Kakimoto; Noriyoshi Mizuno
Journal:  Bone Rep       Date:  2022-01-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.